Skip to main content

Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Sept. 7, 2023 -- Early clean intermittent catheterization is recommended to reduce the incidence of recurrent febrile urinary tract infections (FUTIs) in children with neurogenic bladder (NB), according to a study published in the September issue of Neurourology & Urodynamics.

Guanglun Zhou, from Shenzhen Children’s Hospital in Guangdong, China, and colleagues sought to identify the clinical and urodynamic risk factors associated with the development of recurrent FUTIs in children with NB. The analysis included data for 321 children with NB receiving clean intermittent catheterization (CIC) prospectively followed for two years.

The researchers found that occasional FUTIs occurred in 223 patients, and 98 patients experienced recurrent FUTIs. Late-initiation and low-frequency CIC, vesicoureteral reflux (VUR), small bladder capacity and low compliance, and detrusor overactivity were associated with an increased risk for recurrent FUTIs. Risk for recurrent FUTIs was higher for children with high-grade VUR (grades IV to V) versus those with low-grade VUR (grades I to III; odds ratio, 26.95 versus 4.78; P < 0.001).

“We recommend early CIC interventions in patients with NB,” the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Factors ID'd for Clean Intermittent Catheterization Compliance in Youth With Neurogenic Bladder

WEDNESDAY, May 8, 2024 -- For children with neurogenic bladder, self-catheterization is associated with lower adherence to clean intermittent catheterization (CIC), according to a...

FDA Approves New Antibiotic, Pivya, for Uncomplicated Urinary Tract Infections

TUESDAY, April 30, 2024 -- The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract...

Computer Prompts Could Reduce Empiric Antibiotic Use for UTI

FRIDAY, April 19, 2024 -- For non-critically ill patients with urinary tract infection (UTI), computerized provider order entry (CPOE) prompts providing patient- and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.